Reply to: "Impact of Primary-Site Local Therapy in Patients with De Novo Metastatic Breast Cancer," by Makris, Eleftherios et al

Ann Surg Oncol. 2023 Feb;30(2):1072-1073. doi: 10.1245/s10434-022-12873-7. Epub 2022 Dec 3.

Authors

Seema Ahsan Khan¹, Steven Schuetz², Omid Hosseini²

Affiliations

¹ Department of Surgery, Feinberg School of Medicine of Northwestern University, Chicago, USA. s-khan2@northwestern.edu.
² Texas Tech University Health Sciences Center School of Medicine, Lubbock, USA.

PMID: 36463357
DOI: 10.1245/s10434-022-12873-7

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms* / pathology
Breast Neoplasms* / therapy
Female
Humans
Prognosis
Receptor, ErbB-2

Substances

Receptor, ErbB-2